Parallax Volatility Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,000
Closed -$6.55M 1454
2025
Q4
$6.55M Hold
20,000
0.01% 595
2025
Q3
$5.64M Sell
20,000
-100
-0.5% -$29K 0.01% 644
2025
Q2
$5.61M Sell
20,100
-155,900
-89% -$44.2M 0.01% 597
2025
Q1
$54.8M Sell
176,000
-2,900
-2% -$856K 0.15% 115
2024
Q4
$46.6M Sell
178,900
-305,900
-63% -$90.8M 0.09% 167
2024
Q3
$156M Buy
484,800
+131,900
+37% +$43.1M 0.28% 62
2024
Q2
$110M Sell
352,900
-112,900
-24% -$33.2M 0.24% 75
2024
Q1
$132M Buy
465,800
+199,300
+75% +$58.3M 0.3% 54
2023
Q4
$76.8M Buy
266,500
+153,900
+137% +$41.9M 0.16% 122
2023
Q3
$30.3M Sell
112,600
-91,300
-45% -$22.8M 0.07% 228
2023
Q2
$45.3M Buy
203,900
+21,900
+12% +$5.08M 0.1% 172
2023
Q1
$44M Sell
182,000
-59,700
-25% -$14.7M 0.09% 216
2022
Q4
$63.5M Sell
241,700
-62,100
-20% -$16.6M 0.1% 227
2022
Q3
$68.5M Buy
303,800
+58,200
+24% +$14.1M 0.11% 192
2022
Q2
$59.8M Buy
245,600
+38,600
+19% +$9.46M 0.06% 235
2022
Q1
$50.1M Buy
+207,000
New +$47.6M 0.03% 264
2020
Q4
Sell
-65,800
Closed -$16.7M 2286
2020
Q3
$16.7M Buy
65,800
+61,000
+1,271% +$15.1M 0.01% 790
2020
Q2
$1.13M Sell
4,800
-35,800
-88% -$8.17M ﹤0.01% 1689
2020
Q1
$8.23M Sell
40,600
-289,300
-88% -$63.2M 0.01% 684
2019
Q4
$79.5M Buy
329,900
+52,300
+19% +$11.5M 0.09% 158
2019
Q3
$53.7M Buy
277,600
+135,200
+95% +$26M 0.06% 181
2019
Q2
$26.2M Sell
142,400
-15,000
-10% -$2.69M 0.03% 282
2019
Q1
$29.9M Sell
157,400
-648,800
-80% -$124M 0.03% 241
2018
Q4
$157M Buy
806,200
+774,700
+2,459% +$151M 0.21% 69
2018
Q3
$6.53M Buy
+31,500
New +$6.21M 0.01% 623
2018
Q2
Sell
-150,000
Closed -$25.6M 2068
2018
Q1
$25.6M Buy
+150,000
New +$27.5M 0.03% 210
2017
Q4
Sell
-100,000
Closed -$18.6M 3914
2017
Q3
$18.6M Sell
100,000
-191,300
-66% -$33.9M 0.03% 280
2017
Q2
$50.2M Buy
291,300
+167,500
+135% +$27.2M 0.1% 125
2017
Q1
$20.3M Buy
123,800
+76,200
+160% +$12.7M 0.04% 237
2016
Q4
$6.96M Sell
47,600
-75,000
-61% -$11.3M 0.01% 551
2016
Q3
$20.5M Sell
122,600
-101,500
-45% -$17.2M 0.04% 274
2016
Q2
$34.1M Buy
224,100
+204,100
+1,021% +$31.7M 0.07% 197
2016
Q1
$3M Sell
20,000
-9,400
-32% -$1.4M 0.01% 752
2015
Q4
$4.77M Buy
29,400
+4,400
+18% +$692K 0.01% 696
2015
Q3
$3.46M Sell
25,000
-7,800
-24% -$1.23M 0.01% 793
2015
Q2
$5.04M Buy
32,800
+22,800
+228% +$3.65M 0.01% 710
2015
Q1
$1.6M Sell
10,000
-91,900
-90% -$14.5M ﹤0.01% 1099
2014
Q4
$16.2M Buy
101,900
+70,800
+228% +$11M 0.05% 344
2014
Q3
$4.37M Sell
31,100
-106,300
-77% -$13.9M 0.01% 768
2014
Q2
$16.3M Buy
137,400
+119,300
+659% +$13.8M 0.07% 215
2014
Q1
$2.23M Sell
18,100
-38,000
-68% -$4.61M 0.01% 556
2013
Q4
$6.4M Sell
56,100
-109,900
-66% -$12.5M 0.03% 380
2013
Q3
$18.6M Buy
166,000
+60,300
+57% +$6.54M 0.1% 179
2013
Q2
$10.4M Buy
+105,700
New +$11M 0.05% 263

Other funds holding AMGN

Parallax Volatility Advisers's AMGN Position: Q1 2026 in Review

Parallax Volatility Advisers increased its Amgen (AMGN) stake by 239,400% in Q1 2026, buying an estimated $1.71M and bringing the position to 4,790 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Parallax Volatility Advisers first reported a position in AMGN in Q1 2014 and has held it in 33 quarters since. The position peaked at $37.1M in Q4 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Parallax Volatility Advisers held 4,790 shares of Amgen worth $1.65M as of Q1 2026.
  • Parallax Volatility Advisers bought 4,788 Amgen shares in Q1 2026, an estimated $1.71M.
  • Amgen made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #837 holding.
  • Parallax Volatility Advisers first reported a position in Amgen in Q1 2014 and has held it in 33 quarters since.
  • Parallax Volatility Advisers's Amgen position peaked at $37.1M in Q4 2019.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.